Pharma-Bio Serv (PBSV) Interest & Investment Income (2010 - 2016)
Pharma-Bio Serv's (PBSV) quarterly Interest & Investment Income came in at -$4255.0 in Q2 2016, up 76.05% on a YoY basis from -$2416.9 in Q2 2015, and up 37.87% quarter-over-quarter from -$6849.0 in Q1 2016.
Powered by 
Analysis
Pharma-Bio Serv (PBSV) Interest & Investment Income (2010 - 2016) Analysis & Trends
Pharma-Bio Serv (PBSV) has reported Interest & Investment Income for 7 consecutive years, with -$4255.0 the latest figure, recorded in Q2 2016.
- For the quarter ending Q2 2016, Interest & Investment Income rose 76.05% year-over-year to -$4255.0; the trailing twelve-month figure through Apr 2016 stood at -$25686.0 (down 51.03% YoY), and the FY2015 full-year result was -$34448.0, down 918.27% from the prior year.
- Interest & Investment Income rose to -$4255.0 in Q2 2016 per PBSV's latest filing, from -$6849.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $4286.0 in Q2 2014 and bottomed at -$31452.0 in Q2 2013.
- Historically, Interest & Investment Income has averaged -$6263.0 across 5 years, with a median of -$2097.0 in 2015.
- The sharpest annual moves came in 2013 and 2014: Interest & Investment Income tumbled 1531.59% in 2013, then soared 113.63% in 2014.
- Over 5 years, Interest & Investment Income stood at $2775.0 in 2012, then sank by 955.5% to -$23740.0 in 2013, then surged by 93.99% to -$1427.0 in 2014, then grew by 29.29% to -$1009.0 in 2015, then sank by 321.7% to -$4255.0 in 2016.
- According to Business Quant data, Interest & Investment Income over the past three periods registered -$4255.0, -$6849.0, and -$1009.0 for Q2 2016, Q1 2016, and Q4 2015 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 124.62 Bn | 115.58 Bn | 6.13 Bn | 75.07 Mn |
| 2 | UL Solutions | 14.92 Bn | 14.51 Bn | 417.00 Mn | - |
| 3 | Gartner | 11.76 Bn | 10.28 Bn | 1.19 Bn | - |
| 4 | Tetra Tech | 9.19 Bn | 8.96 Bn | 243.21 Mn | - |
| 5 | Booz Allen Hamilton Holding | 8.76 Bn | 8.22 Bn | 1.46 Bn | -48.00 Mn |
| 6 | Genpact | 6.27 Bn | 5.75 Bn | 490.34 Mn | -15.15 Mn |
| 7 | Korn Ferry | 4.28 Bn | 3.15 Bn | 685.99 Mn | -5.06 Mn |
| 8 | Fti Consulting | 4.20 Bn | 4.04 Bn | 316.27 Mn | -401,000.00 |
| 9 | Grand Canyon Education | 4.01 Bn | 3.73 Bn | 204.08 Mn | 2.70 Mn |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2016 | -4,255.00 |
| Jan 31, 2016 | -6,849.00 |
| Oct 31, 2015 | -1,009.00 |
| Jul 31, 2015 | -13,573.00 |
| Apr 30, 2015 | -17,769.00 |
| Jan 31, 2015 | -2,097.00 |
| Jul 31, 2014 | -1,427.00 |
| Apr 30, 2014 | 4,286.00 |
| Jan 31, 2014 | -7,136.00 |
| Oct 31, 2013 | -23,740.00 |
| Apr 30, 2013 | -31,452.00 |
| Oct 31, 2012 | 2,775.00 |
| Jul 31, 2012 | 2,320.00 |
| Apr 30, 2012 | 2,197.00 |
| Jan 31, 2012 | 3,784.00 |
| Oct 31, 2011 | 5,260.00 |
| Jul 31, 2011 | 5,330.00 |
| Apr 30, 2011 | 4,354.00 |
| Jan 31, 2011 | 4,765.00 |
| Oct 31, 2010 | 3,049.00 |